M
10b5-1 Plan
$ Value
$26K
Shares
125
Price
$209
Filed
Dec 2
Insider
Name
Curet Myriam
Title
EVP & Chief Medical Officer
CIK
0001632901
Roles
Officer
Transaction Details
Transaction Date
2025-12-01
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
125
Footnotes
The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026. | Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
Filing Info
Curet Myriam's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-10 | ISRG | M | $24K |
| 2026-03-10 | ISRG | ▼ | $52K |
| 2026-03-10 | ISRG | M | $0 |
| 2026-03-03 | ISRG | ▼ | $2.3M |
| 2026-03-02 | ISRG | M | $26K |
| 2026-03-02 | ISRG | ▼ | $62K |
| 2026-03-02 | ISRG | M | $0 |
| 2026-02-28 | ISRG | M | $0 |
| 2026-02-28 | ISRG | F | $250K |
| 2026-02-28 | ISRG | M | $0 |
Other Insiders at ISRG (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
WADORS PATRICIA L
SVP Chief Human Resources Offi
|
— | $110K | 2026-02-27 |
| GUTHART GARY S | — | $14.5M | 2026-02-28 |
|
Samath Jamie
EVP & CFO & Enterprise Technol
|
— | — | 2026-02-28 |
| Leonard Keith R | — | — | 2026-01-29 |
|
Rosa David J.
Chief Executive Officer (CEO)
|
— | — | 2026-02-28 |
|
LOEB GARY
EVP & Chief Legal and Complian
|
— | — | 2026-02-28 |
|
Curet Myriam
EVP & Chief Medical Officer
|
— | $4.0M | 2026-03-10 |
|
Charlton Henry L
EVP & Chief Commercial and Mkt
|
— | — | 2026-02-28 |
|
Widman Fredrik
VP Corporate Controller
|
— | $248K | 2026-03-03 |
|
Brosius Mark
SVP & Chief Mfg and Supply Cha
|
— | $2.4M | 2026-03-09 |
|
Jeddi Iman
SVP & GM da Vinci Platforms &
|
— | — | 2026-02-28 |